The Bioss Blog

News, updates, and analysis from the world of research. Interested in having your work with Bioss' products featured on the site? Email marketing@biossusa.com for more information.

Be sure to follow us on Twitter and Facebook for regular updates.

Bioss to Attend AACR 2019 in Atlanta

The Bioss team is excited to be traveling to Atlanta, GA, at the end of March for the annual meeting of the American Association for Cancer Research. The meeting will take place from March 29 to April 3 at the Georgia World Congress Center.

In Search for ALS Therapies, Researchers Turn to Protein Interactions

Amyotrophic lateral sclerosis (ALS) — also known as Lou Gehrig’s disease — is a progression motor neuron disease characterized by loss of muscle tissue and impaired movement. The genetic underpinnings of the disease are complex and not understoodfalse

Introduction to Recombinant Rabbit Monoclonal Antibodies

The production of monoclonal antibodies dates back to 1975 when Köhler and Milstein first described the fusion of immunized mouse spleen B cells with cancerous myeloma cells, resulting in hybridoma cells that are both immortal and secrete a specificfalse

9 Science Books for Winter Reading

Winter is a great time to relax at home with some good science reads. Here are some of our favorites this season to expand your mind and get through the coldest months:

View the Results from IgGy's Tower at SfN 2018

The Bioss Team is happy to announce the results from the IgGy's Tower activity at Neuroscience 2018 in San Diego. Over the four-day conference, more than 1400 people visited the booth and helped construct the nearly 8-foot tower using more thanfalse

Research Spotlight: No More Dry Eyes?

Multifactorial chronic ocular surface disease — also known as “dry eye” — greatly affects quality of life and can lead to loss of vision in severe cases. Inflammation and instability of the tear film, the protective layer around the eye, can leadfalse

Antibody Manufacturing: The Power of Small Peptides

Antibodies — also referred to as immunoglobulins — represent one of the most powerful tools available for life science researchers. Experimentalists want an antibody that is both specific to their target of interest and sensitive enough for theirfalse